Technology

March 29, 2012 — VectraCor Inc. announced at the American College of Cardiology’s 61st Annual Scientific Session (ACC) in Chicago that it received U.S. Food and Drug Administration (FDA) approval for the VectraplexECG System with VectraplexAMI. It is a stand-alone cardiac monitor/electrocardiography (ECG) machine with a cardiac electric biomarker (CEB) for real-time detection of ECG changes that may be indicative of an acute myocardial infarction (AMI) plus the capability to derive a 15-lead ECG.

Home March 29, 2012
Home
The GE Healthcare ValveAssist software enables trans-aortic valve replacement (TAVR) procedural planning and guidance with integration on live fluoro imaging.
Feature | Dave Fornell

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A couple of key trends were evident on the show floor – new technology to support trans-aortic valve replacement (TAVR) and the launch of new cardiovascular image and information systems (CVIS) to support healthcare’s proposed Stage 2 meaningful use (MU) requirements.

Home March 29, 2012
Home
Technology

March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for multiple enhancements to its PressureWire Fractional Flow Reserve (FFR) measurement guidewire. FFR measurement identifies the severity of narrowings in the coronary arteries and allows for a more effective assessment of coronary lesions, or blockages, resulting in more accurate diagnosis and improved appropriate treatment of coronary artery blockages.

Home March 29, 2012
Home
Technology

March 29, 2012 — Siemens Healthcare recently expanded its solutions portfolio by offering the RaySafe i2 personal dosimetry system as an accessory for all Siemens Artis zee angiography systems. By using RaySafe i2 during imaging procedures, medical personnel obtain real-time information regarding their levels of radiation exposure, enabling them to take immediate steps to minimize exposure and establish a high-functioning radiation safety culture within their hospital.

Home March 29, 2012
Home
This is a cardiac CT scan that has been reconstructed as a 3D image of the heart. The ACRIN-PA study looked at use of cardiac CT to evaluate chest pain patients in the emergency room.
Feature | Cardiac Imaging

Two large clinical trials were presented in the late-breaking clinical trials session at the American College of Cardiology's (ACC) 61st Annual Scientific Session this week that indicate coronary computed tomography angiography (CCTA) used as a tool to evaluate patients with chest pain in the emergency department is safe, time-efficient and cost-effective, compared to the current standard approach.

Home March 28, 2012
Home
Technology

Agfa HealthCare's new modular version of its cardiovascular information system (CVIS), Impax CV12, was unveiled at the American College of Cardiology (ACC) Annual Scientific Session this week in Chicago.

Home March 27, 2012
Home
Technology

GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College of Cardiology (ACC) 2012.

Home March 27, 2012
Home
Feature

New evidence shows that with appropriate preparation, angioplasty can be safely and effectively performed at community hospitals without on-site cardiac surgery units. This was according to data presented from the CPORT-E trial during the American College of Cardiology's (ACC) 61st Annual Scientific Session this week in Chicago.

Home March 27, 2012
Home
Feature

Coronary angiography is unable to accurately predict the severity of vessel narrowing, suggesting fractional flow reserve (FFR) functional tests should be added to help determine if a patient needs revascularization. This was according to research presented from the IRIS FFR-DEFER trial at the American College of Cardiology's (ACC) 61st Annual Scientific Session this week in Chicago.

Home March 27, 2012
Home
Feature

The cost to place an implantable cardioverter-defibrillator (ICD) increased by $844 per case after a new requirement from the Centers for Medicare and Medicaid Services (CMS) went into effect in February 2010, which has added little additional benefit for patients. This was according to research presented during the American College of Cardiology’s 61st Annual Scientific Session in Chicago this week.

Home March 27, 2012
Home
Feature

March 27, 2012 – Researchers found the antiplatelet drug abciximab significantly decreased damage to the heart muscle in patients with ST-segment-elevation myocardial infarction (STEMI), the most severe type of heart attack. Results of INFUSE-AMI trial were presented at the American College of Cardiology’s 61st Annual Scientific Session and published simultaneously in the March 25 online issue of the Journal of the American Medical Association. Researchers also found that clot aspiration did not significantly reduce the damage to the heart muscle.

Home March 27, 2012
Home
Feature

Biodegradable polymer drug-eluting stents (DES) provide better long-term safety and efficacy than durable polymer DES, according to findings from an analysis of three major clinical trials — ISAR-TEST 3, ISAR-TEST 4 and LEADERS. The data were presented at at the American College of Cardiology’s 61st Annual Scientific Session.

Home March 27, 2012
Home
Technology

March 26, 2012 — ScImage Inc. launched a new cloud electrocardiogram (ECG) management service as an extension of its PicomCloud cloud picture archiving and communications system (PACS) at the American College of Cardiology's (ACC) 61st Annual Scientific Session in Chicago.

Home March 26, 2012
Home
News

March 26, 2012 - New research shows that the addition of two magnetic resonance imaging (MRI) sequences to a common MR angiography technique significantly improves detection of pulmonary embolism, a potentially life-threatening condition traditionally diagnosed through computed tomography (CT). Results of the study are published online in the journal Radiology.

Home March 26, 2012
Home
Technology

March 26, 2012 — Itamar-Medical unveiled its cardiovascular healthcare assessment platform, EndoPAT-MF, at the American College of Cardiology’s 61st Annual Scientific Session (ACC.12) in Chicago. The multifunction EndoPAT-MF now features five major diagnostic tools in a single system.

Home March 26, 2012
Home
Subscribe Now